A study of the effect of the irreversible delta receptor antagonist [d-Ala2,Leu5,Cys6]Enkephalin on δcx and δncx opioid binding sites in vitro and in vivo

This publication has 12 references indexed in Scilit:

• Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes
  Life Sciences, 1991
• Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence
  Peptides, 1991
• Pharmacological characterization of [D-Ala2,Leu5,Ser6]enkephalin (DALES): antinociceptive actions at the δnon-complexed-opioid receptor
  European Journal of Pharmacology, 1991
• Naltrindole-5'-isothiocyanate: a nonequilibrium, highly selective .delta.-opioid receptor antagonist
  Journal of Medicinal Chemistry, 1990
• Chronic administration of morphine and naltrexone up-regulate[3H][d-ala2,d-leu5]enkephalin binding sites by different mechanisms
  Neuropharmacology, 1988
• Fentanyl isothiocyanate reveals the existence of physically associated μ- and δ-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum
  European Journal of Pharmacology, 1988
• LY164929: a highly selective ligand for the lower affinity [3H]D-Ala2-D-Leu-5-enkephalin binding site
  Neuropeptides, 1988
• Effects of stress and β-funal trexamine pretreatment on morphine analgesia and opioid binding in rats
  Life Sciences, 1987
• Irreversible Ligands with High Selectivity Toward δ and μ Opiate Receptors
  Science, 1983
• The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone
  European Journal of Pharmacology, 1981